Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
CCDC88A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TANK - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MAD2L1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SOAT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LRRC58 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IFT80 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
DCK - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PBRM1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RAD23B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CACYBP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PPP1R2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ANKRD13C - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RCBTB1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
HNRNPA1P33 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
HINT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PRRC2C - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NUP50 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LHX4 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MRPL50 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on